Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Published July 7, 2016
Citation Information: JCI Insight. 2016;1(10):e80920. https://doi.org/10.1172/jci.insight.80920.
View: Text | PDF
Research Article Cardiology Neuroscience Stem cells Transplantation Vascular biology

ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction

  • Text
  • PDF
Abstract

Cardiovascular progenitor cells (CPCs) expressing the ISL1-LIM–homeodomain transcription factor contribute developmentally to cardiomyocytes in all 4 chambers of the heart. Here, we show that ISL1-CPCs can be applied to myocardial regeneration following injury. We used a rapid 3D methylcellulose approach to form murine and human ISL1-CPC spheroids that engrafted after myocardial infarction in murine hearts, where they differentiated into cardiomyocytes and endothelial cells, integrating into the myocardium and forming new blood vessels. ISL1-CPC spheroid–treated mice exhibited reduced infarct area and increased blood vessel formation compared with control animals. Moreover, left ventricular (LV) contractile function was significantly better in mice transplanted with ISL1-CPCs 4 weeks after injury than that in control animals. These results provide proof-of-concept of a cardiac repair strategy employing ISL1-CPCs that, based on our previous lineage-tracing studies, are committed to forming heart tissue, in combination with a robust methylcellulose spheroid–based delivery approach.

Authors

Oscar Bartulos, Zhen Wu Zhuang, Yan Huang, Nicole Mikush, Carol Suh, Alda Bregasi, Lin Wang, William Chang, Diane S. Krause, Lawrence H. Young, Jordan S. Pober, Yibing Qyang

×

Figure 2

Mouse ISL1-CPC spheroid–derived cells in infarcted hearts.

Options: View larger image (or click on image) Download as PowerPoint
Mouse ISL1-CPC spheroid–derived cells in infarcted hearts.
(A) Biolumine...
(A) Bioluminescent images in a representative live animal injected with mISL1-CPC spheroids and recorded at 3 different time points: left (72 hours); middle (2 weeks); right (4 weeks). The far right: Graph representing the bioluminescence signal quantified in live animals injected with mISL1-CPC spheroids, n = 7. Statistical analysis performed with 1-way repeated measurements ANOVA with Greenhouse-Geisser correction (P = 0.35). (B) Bioluminescent image of a heart explanted 4 weeks after artery ligation and injection with mISL1-CPC spheroids. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right ventricle. In A and B, the numbers in the scale bars were introduced manually to enlarge the font size. (C and D) Histological sections of explanted hearts 4 weeks after surgery, showing that mISL1-CPC spheroids differentiated into cardiomyocytes (C) and endothelial cells (D). Note the integration of donor endothelial cells in host blood vessels. Pictures in C represent ×10 (left), ×20 (second and third from left), and ×60 (fourth and fifth from left) magnification. Pictures in D represent ×10 (left), ×20 (second from left), and ×60 (third and fourth from left) magnification. White rectangles in ×10 and ×20 pictures represent the area magnified in ×20 and ×60, respectively. Y-chromosome FISH staining (red), cTnT (green), and CD31 (cyan). White arrowheads indicate the location in the ×60 pictures of Y-FISH+/cTnT+ and Y-FISH+/CD31+ cells in C and D, respectively. Scale bars: 100 μm in ×10, 50 μm in ×20, and 20 μm in ×60 pictures. (E) Quantification of double-positive Y-FISH/cTnT, Y-FISH/CD31, and Y-FISH/SMA cells in 4 infarcted hearts 4 weeks after surgery/cell injection. Seven slides, containing coronal sections, were analyzed per heart in the anatomical region where the bioluminescence was detected. See also Supplemental Figures 3 and 4.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts